Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia
M Waibel; S J Vervoort; I Y Kong; S Heinzel; K M Ramsbottom; B P Martin; E D Hawkins; R W Johnstone
Author Information: Cancer Therapeutics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.